Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Neoadjuvant treatment;”
Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
ClinicalTrials.gov study NCT06015035. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
ClinicalTrials.gov study NCT06189846. IPD Sharing: NO. Countries: 5. Publications: 0.
Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Ra
ClinicalTrials.gov study NCT03368131. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC
ClinicalTrials.gov study NCT05172440. IPD Sharing: NO. Countries: 1. Publications: 0.
Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
ClinicalTrials.gov study NCT07063901. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC
ClinicalTrials.gov study NCT04664972. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
ClinicalTrials.gov study NCT05862168. IPD Sharing: NO. Countries: 1. Publications: 0.
Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid
ClinicalTrials.gov study NCT04777604. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC
ClinicalTrials.gov study NCT07018947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT01483014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy
ClinicalTrials.gov study NCT01594177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platform Trial Evaluating Treatment of Neoadjuvant Trastuzumab-deruxtecan Containing Combination Therapies for HER2+, Resectable Esophagogastric Adenocarcinoma
ClinicalTrials.gov study NCT06731803. IPD Sharing: NO. Countries: 1. Publications: 0.
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06361940. IPD Sharing: NO. Countries: 1. Publications: 0.
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
ClinicalTrials.gov study NCT06587061. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07371208. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC
ClinicalTrials.gov study NCT06003673. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)
ClinicalTrials.gov study NCT01069770. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
ClinicalTrials.gov study NCT06714383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC
ClinicalTrials.gov study NCT04067102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
ClinicalTrials.gov study NCT06055738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.